Harvard Bioscience, Inc. HBIO
Set alert
8.78 USD +0.18 +2.09%
As of Nov 3, 10:28 AM ET
8.60 Day range 8.65
4.00 52-week range 9.10
- YTD
- +31.04%
- 1 year
- +54.04%
- Open
- 8.60
- Prev close
- 8.60
- Mkt cap
- 39.38M
- Vol
- 1.52K
- Avg vol
- 19.51K
- EPS
- -2.31
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.60
- High
- 8.65
- Forward P/E
- 14.00
- Beta
- 1.31
- Short ratio
- 2.66
- Inst. own
- 75.99%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.30
- 200-d avg
- 3.04
- 1y target
- 6.25
MAX chart
Events in this range
- Nov 3, 2013Split: 1.319 for 1
- Nov 4, 2013Split: 1319 for 1000
- Aug 5, 2022Rating: Keybanc · — → Overweight
- Mar 7, 2024Earnings: 0.01; estimate 0.05; surprise -80%
- May 7, 2024Earnings: 0.02; estimate 0.02; surprise 0%
- May 7, 2024Earnings: 0; estimate 0.02; surprise —%
- Nov 7, 2024Earnings: -0.02; estimate 0.05; surprise -140%
Signals (95)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| SMA: Bullish | Feb 1, 2026 | 9 months ago |
| SMA: Bearish | Jan 1, 2026 | 10 months ago |
| MACD: Buy Signal | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 1, 2025 | 1 year ago |
| RSI: Oversold | Feb 1, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 1, 2024 | 2 years ago |
| SMA: Bearish | Jan 1, 2024 | 2 years ago |
| SMA: Bearish | Jan 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| SMA: Bearish | Oct 1, 2023 | 3 years ago |
| SMA: Bearish | Jul 1, 2023 | 3 years ago |
| SMA: Bullish | Apr 1, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 1, 2023 | 3 years ago |
| SMA: Bullish | Mar 1, 2023 | 3 years ago |
| SMA: Bearish | May 1, 2022 | 4 years ago |
| MACD: Sell Signal | Feb 1, 2022 | 4 years ago |
| SMA: Bearish | Nov 1, 2021 | 5 years ago |
Newest 20 of 95.
Analyst view
Consensus: none
Price target (mean) 6.25 -28.8% downside
Now 8.78
- Target (low)
- 5.50
- Target (mean)
- 6.25
- Target (high)
- 7.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.05 | 0.04 – 0.06 | 0.04 | +25.0% | 24.15M | -14.2% | 2 |
| Next quarter | 0.015 | -0.01 – 0.04 | 0.02 | -25.0% | 22.95M | -6.4% | 2 |
| Current year | 0.045 | 0.00 – 0.09 | 0.14 | -67.9% | 93.75M | -16.5% | 2 |
| Next year | 0.125 | 0.07 – 0.18 | 0.045 | +177.8% | 97.80M | +4.3% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 22, 2023 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Apr 26, 2023 | Benchmark | Maintained | — | Buy |
| Apr 26, 2023 | Keybanc | Maintained | — | Overweight |
| Mar 10, 2023 | Benchmark | Reiterated | — | Buy |
| Nov 9, 2022 | Keybanc | Maintained | — | Overweight |
| Aug 5, 2022 | Keybanc | Maintained | — | Overweight |
| Nov 10, 2020 | Keybanc | Initiated | — | Overweight |
| Feb 27, 2020 | Benchmark | Maintained | — | Speculative Buy |
| Nov 17, 2016 | Singular Research | Initiated | — | Buy |
| Jul 28, 2015 | Benchmark | Initiated | — | Buy |
| Nov 26, 2013 | Sidoti & Co. | Upgrade | Neutral | Buy |